Funder: National Institutes of Health

Due Dates: June 12, 2025 (New) | July 12, 2025 (Renewal/Resubmission) | October 12, 2025 (New) | November 12, 2025 (Renewal/Resubmission) | February 12, 2026 (New) | March 12, 2026 (Renewal/Resubmission) | June 12, 2026 (New) | July 12, 2026 (Renewal/Resubmission) | October 12, 2026 (New) | November 12, 2026 (Renewal/Resubmission) | February 12, 2027 (New) | March 12, 2027 (Renewal/Resubmission) | June 12, 2027 (New) | July 12, 2027 (Renewal/Resubmission)

Funding Amounts: Up to $75,000/year (K99 phase) or $125,000/year for licensed clinicians, plus $20,000 research costs; R00 phase up to $249,000/year (total costs); max 5 years (2 years K99, 3 years R00).

Summary: Supports postdoctoral researchers from diverse backgrounds in Alzheimer's disease-related dementias to transition to independent, tenure-track faculty positions; clinical trials as lead investigator are not allowed.

Key Information: Applicants must have ≤4 years postdoc experience and propose research focused on AD/ADRD; no independent clinical trials permitted.